Oxygen Biotherapeutics, Inc. (OXBO) Issues Letter to Shareholders  
8/7/2013 10:00:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced the Company has issued a Letter to Shareholders.

Help employers find you! Check out all the jobs and post your resume.